Market Overview

Sunshine Heart to Present Hemodynamic Data Supporting Mechanism of Action of C-Pulse System at TCT Conference

Share:

Sunshine Heart, Inc. (NASDAQ: SSH) announced today that its flagship C-Pulse® Heart Assist System will be featured in a clinical presentation at the 27th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. The TCT symposium will take place October 11th -15th in San Francisco, CA at the Moscone Center.

On Wednesday, October 14th, Dr. Dimitrios Georgakopoulos PhD, Sunshine Heart's Chief Scientific Officer, will present hemodynamic data collected from pre-clinical studies and patients implanted with the C-Pulse device during device optimization and from patients with implantable sensors. These early data presented demonstrate that, in addition to the effects of counterpulsation, C-Pulse may also have a neuromodulation component affecting the parasympathetic and sympathetic nervous systems. Unique insights will be provided from pressure and flow measures obtained in the carotid, coronary and renal circulations and heart rate variability from analysis of individual cardiac cycles. Pilot data applying counterpulsation with C-Pulse to the pulmonary artery in a pre-clinical model of pulmonary hypertension and right heart failure will also be discussed. This oral presentation is entitled "Hemodynamics of C-Pulse: Aortic Counterpulsation and Beyond," and will be part of the Didactic Symposia: Interventional Heart Failure Therapies session. It will

See full press release

 

Related Articles (SSH)

View Comments and Join the Discussion!

Posted-In: News Press Releases